Back to News
Earnings AnalysisDOW

DOW Q1 2026 10-Q: Sadara Guarantee Fair Value +$298M, ~$115M of Q1 Beat Was Accounting

Matt RuncheySHORELINE, WA — April 28, 2026 · 1:30 PM PST7 min

Dow filed its Q1 2026 10-Q on April 24, five days after the $873M EBITDA print. Two disclosures the 8-K did not foreground change the read on Q1. First, the fair value of the Sadara project financing debt guarantee liability rose $298M during the quarter, with management language elevated to “more than remote probability that some future performance under the project financing guarantee may be required.” Second, suspension of Sadara equity loss recognition under ASC 323 provided ~$115M of Q1 EBITDA tailwind. Without the suspension, Q1 EBITDA would have been roughly $758M — still above the $750M guide, but the headline 16% beat is partly accounting-driven. The DOW thesis classification holds at price-below-value with MEDIUM confidence, with Q2 print decomposition (~late July) the next binding test.

The Numbers

+$298M
Sadara Guarantee FV
Q1 mark-to-market through earnings
~$115M
Sadara Suspension Tailwind
Q1 EBITDA ex-suspension ~$758M
$2.0B
Q2 EBITDA Guide
~2.3x Q1; April $0.30/lb included
$80M
First T2O Site Run-Rate
Above initial projection

Sadara: Two New Disclosures the Call Didn't Foreground

The Q1 call covered the suspension of Sadara equity loss recognition — cumulative carrying value of Sadara-related liabilities reached the $1.4B obligation cap ($1.2B project financing debt guarantee + $100M revolver guarantee + $100M letter of credit), so further losses pause under U.S. GAAP. The call did not quantify two related items the 10-Q Note 11 makes explicit:

  • Guarantee liability fair value +$298M Q1. Recorded through earnings as a mark-to-market on the guarantee, not as an impairment of the equity-method investment. The mechanism is mechanically distinct from the dow-2026-sadara-impairment market criterion (which requires a labeled impairment charge on the JV investment), but the direction is unambiguous.
  • Language elevated to “more than remote probability” of future performance under the project financing guarantee. The FY25 10-K used softer phrasing without the explicit probability assertion in this placement. This is the closest the company has come to flagging a near-term cash-call risk on the $1.2B Aramco-relationship debt.
The $115M accounting tailwind decomposes the headline beat
Tate confirmed in Q&A that suspension of Sadara equity loss recognition removed approximately $115M of in-quarter equity loss that would otherwise have flowed. The 8-K release framed Q1 as an “$873M operational beat.” Reconstructed without the suspension, Q1 EBITDA is closer to $758M — still a guide beat, but the variance to the $750M line is operational, not the 16% the headline implied. Full-year Sadara impact estimated ~$400M positive vs. continued recognition. This is a Fugazi Filter watch-list item, not a smoking gun: the suspension is technically correct GAAP. But the Q2 print decomposition will be the first clean read on operational performance vs. accounting-policy relief.

Liquidity Reinforced: Maturity Wall Pushed Out

The 10-Q materially extends the capital structure runway:

  • Revolving credit facility renewed through 2030 (previously 2027 maturity).
  • European A/R securitization renewed through 2029.
  • Cash >$4.0B at March 31 (up from $3.82B at FY25 close), with ~$300M NOVA tax withholding tail still expected later in 2026.
  • No substantive debt maturities until 2029.

The dow-2026-sp-downgrade-to-bbb-minus market repriced from 0.25 → 0.10 post-8-K and remains there. The 10-Q reinforces the discount: agency surveillance triggers (proximity to maturity wall, covenant headroom) are now further from breach than at the time of the post-earnings thesis.

Q2 Guide Confirmed; T2O Implementation Cost Quantified

The 10-Q confirms the Q2 2026 guide of ~$12B revenue and approximately $2.0B operating EBITDA — roughly 2.3x the Q1 print. The transcript decomposition: $0.26/lb integrated PE margin improvement, with the April $0.30/lb price increase included and the May $0.20/lb increase NOT in the guide (upside). Carter framed it as “if mid-cycle now, we are moving to peak levels.”

Transform to Outperform implementation cost is now visible for the first time: $53M of T2O costs-to-achieve plus $27M severance in Q1 — roughly $80M total quarterly spend. The first transformation site identified $80M of run-rate EBITDA improvement, well above the initial projection. 25% of large sites have started transformation assessments. The dow-2026-t2o-runrate-above-1b market sits at 0.78 and resolves on Q2 disclosure.

What Didn't Resolve

Zero of the seven active markets are resolvable from this filing. The Q1 EBITDA market was already resolved NO on April 23 from the 8-K (Brier 0.04 — baseline 0.20 well-calibrated). The 10-Q + transcript update sharpens the read but defers the catalysts:

  • Q2 2026 earnings (~late July) — binding for T2O run-rate disclosure and operational-vs-accounting decomposition.
  • Sadara strategic review midyear update — Fitterling committed to a midyear update on the Aramco restructuring before his July 1 transition to Executive Chair.
  • Sadara guarantee liability fair value Q2/Q3 — does the “more than remote probability” language escalate further, or does the strategic review crystallize a resolution?
  • April $0.30/lb realization + May $0.20/lb settlement — direct test of pricing power thesis at the Q2 print.
The bullish re-pricing still rests on inferred trajectory
The April 24 thesis priced the Q2 $2.0B guide and the Sadara suspension correctly at a high level. The 10-Q is incremental, not regime-changing — net mildly bullish on liquidity, net mildly bearish on Sadara tail, with a Fugazi Filter caveat on the headline beat decomposition. The prediction ensemble's recovery probabilities continue to outpace the $38.37 stock price, but the bull case now sits on three unresolved legs: Q2 delivery vs. guide, T2O run-rate disclosure clearing $1B, and the Sadara strategic review outcome. A Q2 EBITDA miss combined with a Sadara guarantee call would trigger simultaneous downgrades across four lens assessments.

See the full eight-lens DOW analysis

The April 2026 DOW deep-dive with the Gravy Gauge, Stress Scanner, Myth Meter, Roadkill Radar, Fugazi Filter, Moat Mapper, Insider Investigator, and Black Swan Beacon outputs, plus the seven active forecast markets tracking the thesis after the 10-Q update.

Public Sources Used
  • DOW Q1 2026 Form 10-Q (SEC EDGAR, filed 2026-04-24; period ending 2026-03-31): SEC EDGAR
  • DOW Q1 2026 earnings call transcript (2026-04-23; Chair/CEO James R. Fitterling, COO/CEO-elect Karen S. Carter, CFO Jeffrey L. Tate)
  • DOW Q1 2026 8-K (filed 2026-04-23; baseline reference for the initial earnings article)
  • DOW FY2025 10-K (Sadara Note 11 prior-period comparison)

This report was generated by the Runchey Research AI Ensemble using primary SEC data and reviewed by Matthew Runchey for accuracy.

This analysis is for educational purposes only and does not constitute investment advice. See our Editorial Integrity & Disclosure Policy and Terms of Service.